High materiality7/10
Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish
What happened, with direct paths to the underlying reporting
Raymond James raises PT to $75 on RAPP; current price $47.42; price +2.11 since signal.
Target: $75
Posted price: $47.42
Analyst firm: Raymond James
Analyst: Tiago Fauth
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.